Obstetrics & Gynecology, Gynecologic Oncology · Norfolk, VA
NPI
1740285303
Since 2005
Specialty
Obstetrics & Gynecology, Gynecologic Oncology
Code 207VX0201X
Group practices
1
Medicare group memberships
Hospitals
5
Hospital affiliations
5900 Lake Wright Dr
Norfolk, VA, 23502
Phone (757) 466-8683
Groups this clinician bills Medicare through
Medicare paid, 2024
$1.5M
88,549 services
Medicare patients, 2024
392
Average age 74
Drug cost, 2024
$403K
359 prescriptions
Company payments
-
None reported
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Robert C Squatrito was code J9271 (injection, pembrolizumab, 1 mg), 21,000 times for 16 patients. In total Robert C Squatrito billed 88,549 services in 123 codes, and Medicare paid $1.5M.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2014-09-22.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J9271 Injection, pembrolizumab, 1 mg | Office | 21,000 | 16 | $44.78 | $940K |
| J9267 Injection, paclitaxel, 1 mg | Office | 16,242 | 19 | $0.08 | $1,274 |
| J1453 Injection, fosaprepitant, 1 mg | Office | 11,100 | 24 | $0.11 | $1,276 |
| J0881 Injection, darbepoetin alfa, 1 microgram (non-esrd use) | Office | 10,500 | 11 | $2.36 | $25K |
| J1100 Injection, dexamethasone sodium phosphate, 1 mg | Office | 1,703 | 42 | $0.09 | $151 |
| J2469 Injection, palonosetron hcl, 25 mcg | Office | 1,030 | 31 | $0.71 | $735 |
| 85025 Blood Count | Office | 845 | 73 | $7.61 | $6,430 |
| 80053 Clinical Chemistry | Office | 755 | 66 | $10.35 | $7,814 |
| J1626 Injection, granisetron hydrochloride, 100 mcg | Office | 720 | 17 | $0.24 | $171 |
| J9045 Injection, carboplatin, 50 mg | Office | 645 | 23 | $2.84 | $1,830 |
| 36415 Venipuncture Blood Collection | Office | 620 | 89 | $8.65 | $5,363 |
| 96375 Injection Administration | Office | 557 | 42 | $11.45 | $6,379 |
| 86304 Immunoassay | Office | 369 | 88 | $20.39 | $7,524 |
| 99213 Office E&M - Established | Office | 334 | 244 | $57.63 | $19K |
| 96413 Chemotherapy Administration | Office | 307 | 49 | $96.13 | $30K |
By year: 2022 $990K for 103,606 services; 2023 $1.0M for 100,516 services; 2024 $1.5M for 88,549 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 85025 Blood Count | 845 | 73 | $7.61 | $6,430 |
| 80053 Clinical Chemistry | 755 | 66 | $10.35 | $7,814 |
| 36415 Venipuncture Blood Collection | 620 | 89 | $8.65 | $5,363 |
| 86304 Immunoassay | 369 | 88 | $20.39 | $7,524 |
| 84443 Clinical Chemistry | 136 | 21 | $16.46 | $2,239 |
| 84439 Clinical Chemistry | 134 | 21 | $8.84 | $1,185 |
| 81002 Clinical Chemistry | 134 | 33 | $3.41 | $457 |
| 80048 Clinical Chemistry | 95 | 21 | $8.29 | $788 |
| 82728 Clinical Chemistry | 69 | 34 | $13.36 | $922 |
| 83540 Clinical Chemistry | 69 | 34 | $6.34 | $437 |
Medicare prescription drug claims, 2024
In 2024, the drug Robert C Squatrito prescribed most often to Medicare patients was Prochlorperazine Maleate, with 41 prescriptions and refills. In total Robert C Squatrito wrote 359 Medicare prescriptions that cost $403K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Prochlorperazine Maleate Generic | 41 | 41 | 26 | $457 |
| Letrozole Generic | 30 | 49 | Under 11 | $479 |
| Ondansetron Odt Ondansetron | 30 | 36 | 24 | $590 |
| Megestrol Acetate Generic | 26 | 33 | Under 11 | $1,306 |
| Eliquis Apixaban | 26 | 30 | 23 | $11K |
| Potassium Chloride Generic | 25 | 37 | Under 11 | $224 |
| Rubraca Rucaparib Camsylate | 20 | 20 | Under 11 | $325K |
| Oxycodone-Acetaminophen Oxycodone Hcl/Acetaminophen | 16 | 16 | 16 | $32.51 |
| Xarelto Rivaroxaban | 13 | 21 | Under 11 | $11K |
| Lidocaine-Prilocaine Lidocaine/Prilocaine | 12 | 12 | Under 11 | $170 |
Brand drugs: 77 claims; generic drugs: 282 claims; opioid claims: 38.
Money and other things of value reported by the companies
No payments from drug or medical device companies to Robert C Squatrito were reported in the years we have.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.